Capital Analysts LLC Portfolio holdings
Capital Analysts is a Lincoln Investment company that provides a ready-made wealth management platform to independent financial professionals who serve affluent clients. Capital Analysts dates from 2012 and belongs to Lincoln Investment Capital Holdings; Lincoln Investment Planning, a brokerage and advisory firm under the same ownership, handles brokerage services for it and its advisors. Those advisors work across the United States as independent contractors, not employees. Their clients include individuals, high net worth individuals, trusts, foundations, businesses and charities, and Capital Analysts also offers its institutional advisory services to other advisers and trust companies. The portfolios it builds aim to be diversified and rest on asset allocation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$24.6M |
| 2 |
Goldman Sachs ETF Trust Goldman Sachs S&P 500 Premium Income ETF
GPIX
|
+$16.4M |
| 3 |
Fidelity Total Bond ETF
FBND
|
+$16.1M |
| 4 |
iShares Systematic Alternatives Active ETF
IALT
|
+$16M |
| 5 |
iShares Core Universal USD Bond ETF
IUSB
|
+$11.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoetis
ZTS
|
+$7.72M |
| 2 |
Citigroup
C
|
+$7.28M |
| 3 |
iShares Gold Trust
IAU
|
+$6.25M |
| 4 |
iShares Core US Aggregate Bond ETF
AGG
|
+$6.23M |
| 5 |
iShares MSCI USA Quality Factor ETF
QUAL
|
+$6.21M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 76.75% |
| 2 | Technology | 5.6% |
| 3 | Financials | 4.52% |
| 4 | Industrials | 2.67% |
| 5 | Healthcare | 2.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
826
FT Vest US Equity Moderate Buffer ETF September
GSEP
$363M
| $107K | ﹤0.01% |
2,596
| – | – |
2023 Q3
11 quarters
|
|
827
JPMorgan Diversified Return International Equity ETF
JPIN
$390M
| $107K | ﹤0.01% |
1,476
+19
| +1% | +$1.4K |
2022 Q2
16 quarters
|
|
828
CBRE Group
CBRE
$39.8B
| $106K | ﹤0.01% |
788
-23
| -3% | -$3.17K |
2022 Q3
15 quarters
|
|
829
State Street SPDR Portfolio TIPS Index ETF
SPIP
$1.06B
| $106K | ﹤0.01% |
4,142
+24
| +0.6% | +$622 |
2019 Q1
29 quarters
|
|
830
Innovator US Equity Ultra Buffer ETF November
UNOV
$111M
| $106K | ﹤0.01% |
2,639
| – | – |
2025 Q4
2 quarters
|
|
831
CVS Health
CVS
$109B
| $105K | ﹤0.01% |
1,012
-16
| -2% | -$1.43K |
2013 Q2
52 quarters
|
|
832
iShares 10+ Year Investment Grade Corporate Bond ETF
IGLB
$2.71B
| $105K | ﹤0.01% |
2,101
+1,315
| +167% | +$65.5K |
2026 Q1
1 quarter
|
|
833
Vanguard Intermediate-Term Treasury ETF
VGIT
$41.1B
| $105K | ﹤0.01% |
1,789
+436
| +32% | +$25.8K |
2021 Q1
21 quarters
|
|
834
Consolidated Edison
ED
$43.9B
| $104K | ﹤0.01% |
942
-20
| -2% | -$2.17K |
2021 Q1
21 quarters
|
|
835
GE HealthCare
GEHC
$38B
| $104K | ﹤0.01% |
1,629
-4
| -0.2% | -$263 |
2023 Q1
13 quarters
|
|
836
FT Vest US Small Cap Moderate Buffer ETF November
SNOV
$114M
| $104K | ﹤0.01% |
3,817
| – | – |
2024 Q4
6 quarters
|
|
837
Janus Henderson Transformational Growth ETF
JXX
$20.8M
| $104K | ﹤0.01% |
3,198
+1,260
| +65% | +$38.1K |
2025 Q4
2 quarters
|
|
838
VanEck Gold Miners ETF
GDX
$28.2B
| $103K | ﹤0.01% |
1,353
| – | – |
2024 Q3
7 quarters
|
|
839
Vanguard International Dividend Appreciation ETF
VIGI
$9.31B
| $103K | ﹤0.01% |
1,110
-33
| -3% | -$3.06K |
2024 Q1
9 quarters
|
|
840
Vanguard Short-Term Inflation-Protected Securities Index Fund
VTIP
$21.1B
| $103K | ﹤0.01% |
2,056
-34
| -2% | -$1.71K |
2018 Q2
32 quarters
|
|
841
Capital Group High Yield Bond ETF
CGHY
$131M
| $103K | ﹤0.01% |
+4,055
| New | +$103K |
2026 Q2
0 quarters
|
|
842
Federated Hermes Short Duration High Yield ETF
FHYS
$72.7M
| $102K | ﹤0.01% |
4,417
| – | – |
2022 Q3
15 quarters
|
|
843
Markel Group
MKL
$23.9B
| $102K | ﹤0.01% |
52
| – | – |
2022 Q1
17 quarters
|
|
844
Principal Exchange-Traded Funds Principal US Small-Cap ETF
PSC
$2.7B
| $102K | ﹤0.01% |
1,462
+227
| +18% | +$14.6K |
2025 Q3
3 quarters
|
|
845
Vanguard Utilities ETF
VPU
$8.24B
| $102K | ﹤0.01% |
520
| – | – |
2023 Q4
10 quarters
|
|
846
FT Vest U.S. Equity Max Buffer ETF - September
SEPM
$37.6M
| $102K | ﹤0.01% |
3,107
| – | – |
2025 Q3
3 quarters
|
|
847
Airbnb
ABNB
$112B
| $100K | ﹤0.01% |
696
| – | – |
2021 Q1
21 quarters
|
|
848
Invesco S&P 500 GARP ETF
SPGP
$2.16B
| $100K | ﹤0.01% |
820
-315
| -28% | -$37K |
2018 Q4
30 quarters
|
|
849
Neuberger Option Strategy ETF
NBOS
$541M
| $100K | ﹤0.01% |
+3,572
| New | +$99K |
2026 Q2
0 quarters
|
|
850
Sysco
SYY
$38.6B
| $99K | ﹤0.01% |
1,186
-3
| -0.3% | -$227 |
2019 Q1
29 quarters
|
|
Similar funds
Capital Analysts LLC's Q2 2026 Portfolio in Review
As of Q2 2026, Capital Analysts LLC held 1,612 positions worth $4.34B, up 14% from $3.81B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Capital Analysts LLC deployed $223M of net new capital in Q2 2026, opening 75 new positions and adding to 544 existing holdings. Its largest new stake was iShares Systematic Alternatives Active ETF: 571,327 shares worth $16M.
By sector, the portfolio is most concentrated in Miscellaneous at 77% of assets, up from 75% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Zoetis, an estimated $7.72M trimmed.
- Capital Analysts LLC's largest Q2 2026 buy was iShares Systematic Alternatives Active ETF: 571,327 shares worth $16M.
- Capital Analysts LLC added most to iShares Core S&P 500 ETF in Q2 2026, an estimated $24.6M increase.
- Capital Analysts LLC's biggest Q2 2026 reduction was Zoetis, cutting an estimated $7.72M.
- Capital Analysts LLC fully exited Hershey in Q2 2026, selling an estimated $113K.
- Capital Analysts LLC's ten largest holdings make up 30% of its $4.34B portfolio in Q2 2026.
- Capital Analysts LLC opened 75 new positions and closed 76 in Q2 2026.
- Capital Analysts LLC's portfolio value rose 14% quarter-over-quarter to $4.34B.
Based on Capital Analysts LLC's 13F filing for Q2 2026, filed 5 Aug 2026.